Researchers praise new prostate cancer treatmentThe GuardianA new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men in many countries, including the US and UK. Signage for Zero Prostate Cancer and Novartis AG hangs on the facade of the New York Stock Exchange building on June 20 last year. Photo: BloombergHowever, experts say it has not yet had the same impact on prostate cancer. However, it was important studies were carried out with people of different ethnicities, as there were disparities in prostate cancer outcomes, she said.

Source: Taipei Times March 01, 2026 17:16 UTC